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Summary
 
Haemophilus influenzae
 
 undergoes phase variation in expression of the phosphorylcholine
(ChoP) epitope, a structure present on several invasive pathogens residing in the human re-
spiratory tract. In this study, structural analysis comparing organisms with and without this
epitope confirmed that variants differ in the presence of ChoP on the cell surface–exposed
outer core of the lipopolysaccharide. During nasopharyngeal carriage in infant rats, there was a
gradual selection for 
 
H. influenzae
 
 variants that express ChoP. In addition, genotypic analysis of
the molecular switch that controls phase variation predicted that the ChoP
 
1
 
 phenotype was
predominant in 
 
H. influenzae
 
 in human respiratory tract secretions. However, ChoP
 
1
 
 variants
of nontypable 
 
H. influenzae
 
 were more sensitive to the bactericidal activity of human serum
unrelated to the presence of naturally acquired antibody to ChoP. Serum bactericidal activity
required the binding of C-reactive protein (CRP) with subsequent activation of complement
through the classical pathway. Results of this study suggested that the ability of 
 
H. influenzae
 
 to
vary expression of this unusual bacterial structure may correlate with its ability both to persist
on the mucosal surface (ChoP
 
1
 
 phenotype) and to cause invasive infection by evading innate
immunity mediated by CRP (ChoP
 
2
 
 phenotype).
 
C
 
holine, a major constituent of eukaryotic membrane
lipids, was previously thought to be an unusual struc-
tural feature of prokaryotes. Choline, in the form of cho-
line phosphate or phosphorylcholine (ChoP),
 
1
 
 is found on
the teichoic acid of 
 
Streptococcus pneumoniae
 
 and has recently
been identified as a unique feature of LPS of 
 
Haemophilus
influenzae
 
 (1–3). An mAb, TEPC-15, that specifically rec-
ognizes the ChoP structure has been used to show that the
ChoP epitope is also expressed on pili of pathogenic 
 
Neis-
seriae
 
 and a protein of unknown function in 
 
Pseudomonas
aeruginosa
 
 (reference 4, and Weiser, J.N., J. Goldberg, N.
Pan, L. Wilson, and M. Virji, manuscript submitted for
publication).
In the case of 
 
H. influenzae
 
, choline is acquired from the
environment and linked as ChoP to a hexose on the outer
core region of the LPS (1, 3, 5). Since the LPS of 
 
H. influ-
enzae
 
 lacks the multiple O-linked saccharide units charac-
teristic of the enterobacteriaceae, ChoP is located on the
cell surface. There is both inter- and intrastrain variation in
structure of the LPS as a result of differences in the compo-
sition and linkage of saccharides in the outer core (6-8). An
additional source of heterogeneity of the LPS is phase vari-
ation in the decoration of the LPS with the ChoP epitope.
The expression of the ChoP epitope on the 
 
H. influenzae
 
glycolipid requires the four genes of the 
 
lic1
 
 locus (9). This
locus is present in all strains in a representative survey of
encapsulated and nontypable 
 
H. influenzae
 
 isolates, but is
not required for normal growth in vitro (10). The first gene
in 
 
lic1
 
, 
 
licA
 
, has homology to eukaryotic choline kinases.
This gene contains an unusual feature consisting of variable
numbers of tandem repeats of the sequence 5
 
9
 
-(CAAT)-3
 
9
 
within the open reading frame (11). Variation in the num-
ber of repeat units by slipped-strand mispairing alters the
alignment of initiation codons with the 
 
licA
 
 open reading
frame creating a translational switch that results in sponta-
neous phase variation in expression of the ChoP epitope.
The frequency of on-off switching in the expression of the
ChoP epitope is 
 
z
 
10
 
2
 
2–
 
2
 
3
 
/generation, but varies from
 
1
 
Abbreviations used in this paper:
 
 BHI, brain heart infusion; ChoP, phosphoryl-
choline; CRP, C-reactive protein; ESI-MS, electrospray ionization-mass spec-
trometry; NHS, normal human serum; NMR, nuclear magnetic resonance.
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strain to strain depending on the length of the repetitive se-
quence (1).
A gene with similarity to 
 
licA
 
 has also been noted in 
 
S.
pneumoniae
 
 and in various mycoplasma species, including
 
Mycoplasma fermentans
 
 and 
 
pneumoniae
 
 (12, 13). The pres-
ence of the ChoP epitope on the cell surface of 
 
S. pneumo-
niae
 
, 
 
H. influenzae
 
, 
 
N. meningiditis
 
, and 
 
M. pneumoniae
 
, all
major pathogens residing in the human respiratory tract,
suggests that this structure may contribute to the ability of
these species to occupy their niche on this mucosal surface.
In 
 
S. pneumoniae
 
, 
 
H. influenzae
 
, 
 
N. meningitidis
 
, 
 
N. gonor-
rhoeae
 
, and 
 
P. aeruginosa
 
 there is also phase variation in the
expression of the ChoP epitope (1, 14). Since these patho-
gens also commonly cause invasive infection, we addressed
whether ChoP may contribute to the ability of organisms
to reside in the human nasopharynx as well as their ability
to survive in the bloodstream by evasion of humoral im-
munity. As a model system we have selected 
 
H. influenzae;
 
it has already been documented that ChoP epitope express-
ing variants of a type b 
 
H. influenzae
 
 strain are more sensi-
tive to the bactericidal effect of human serum than variants
lacking this structure (1). It was postulated that the differ-
ence in serum sensitivity was a result of naturally acquired
antibody against ChoP since the serum in this study had
higher immunoglobulin G titers to LPS with the ChoP
epitope compared to LPS without the ChoP epitope.
 
Materials and Methods
 
Bacterial Strains, Media, and Chemicals. H.  influenzae
 
 strains
used for this study included H233, a nontypable clinical isolate
(Strain A860516) obtained from the collection of Dr. Loek van
Alphen (University of Amsterdam, The Netherlands). A kanamy-
cin-resistant encapsulated type b strain (Eagan) and a mutant of
this strain with a deletion/insertion spanning the four genes in 
 
lic1
 
were used in animal experiments (15, 16). Type b strain RM7004
was used for structural analysis (9). 
 
H. influenzae
 
 strains were
grown in brain heart infusion broth supplemented with 1.5%
fildes enrichment with or without 1% agar (Difco Laboratories,
Detroit, MI). When specified, a chemically defined medium was
used with laboratory strain Rd, for which this medium is suitable
(17). Chemicals were purchased from Sigma Chemical Co. (St.
Louis, MO) unless otherwise specified.
 
Structural Analysis of LPS.
 
LPS from TEPC-15–reactive and
nonreactive colonies of strain RM7004 were isolated from BHI
broth-grown cells by the hot phenol-water extraction procedure
(8). Purified LPS were analyzed directly for sugar composition by
complete acid hydrolysis and gas liquid chromatography of the
derived acetylated reduced aldoses (8). 
 
O
 
-deacylated LPS were
prepared by mild hydrazine treatment for comparative analysis by
electrospray ionization–mass spectrometry (ESI-MS) and 
 
1
 
H nu-
clear magnetic resonance (NMR) spectroscopy (18). ESI-MS was
performed in the negative ion mode on a VG Quattro Mass
Spectrometer (Micromass, Manchester, UK) by direct infusion of
samples in 25% aqueous acetonitrile containing 0.5% acetic acid.
 
1
 
H NMR spectra were recorded at 500 MHz on samples in D
 
2
 
O
at 37
 
8
 
C on a Bruker AMX 500 spectrometer with acetone (methyl
resonance: 
 
d
 
 2.225 ppm) as the internal chemical shift standard.
 
Colony Immunoblotting.
 
Colonies lifted onto nitrocellulose
were immunoblotted to separate phase variants as previously de-
scribed (1). The ChoP epitope on colonies lifted onto nitrocellu-
lose was detected using a 1:10,000 dilution of mAbs against
ChoP, TEPC-15, or HAS (Statens SerumInstitut, Copenhagen,
Denmark), followed by alkaline phosphatase–conjugated anti–
mouse IgA or IgM, respectively. In samples obtained from nasal
washes, 20–200 colonies from each pup were immunoblotted to
determine the proportion of ChoP
 
1
 
 and 
 
2
 
 colonies. After deter-
mining the phenotype with respect to ChoP expression, a single
colony was used to inoculate 5-ml BHI broth cultures for extrac-
tion of chromosomal DNA for use as a template for the PCR by
a published method (19).
 
Western Blot Transfer and Immunoblotting.
 
Electrotransfer of
proteins separated on 12% SDS-PAGE onto Immobilon-P (Milli-
pore Co., Bedford, MA) and Western blotting were carried out as
previously described (1). Depletion of C-reactive protein (CRP)
and/or IgG from the pooled normal human serum (NHS) was
confirmed by Western blot analysis using an mAb to human CRP
and polyclonal serum against human IgG, respectively.
 
Serum Bactericidal Assays.
 
Complement-mediated serum bac-
tericidal activity was determined in NHS pooled from six random
adult donors and stored at 
 
2
 
80
 
8
 
C. Assays were performed with
20 
 
m
 
l of a suspension of midlog phase organisms (OD
 
620
 
 0.3–0.4)
diluted to 10
 
5
 
 CFU/ml with HBSS (GIBCO BRL, Gaithersburg,
MD), 60 
 
m
 
l HBSS, 100 
 
m
 
l PBS, and 20 
 
m
 
l pooled NHS. After
incubation for 60 min at 37
 
8
 
C with rotation, the assay was
stopped by cooling to 4
 
8
 
C and dilutions were made for quantita-
tive culture. To calculate the percentage of survival, colony
counts were compared to controls in which complement activity
had been eliminated by prior heating of the NHS to 56
 
8
 
C for 30
min. IgG was removed from NHS using a protein G column ac-
cording to the manufacturer’s instructions (Pharmacia Biotech
AB, Uppsala, Sweden). CRP was removed from the NHS by in-
cubation at 4
 
8
 
C for 30 min with an equal volume of ChoP-cou-
pled agarose beads (Pierce Chemical Co., Rockford, IL) that had
been washed in 0.02 M Tris (pH 7.2), 0.15 M NaCl, and 10 mM
CaCl
 
2
 
. Purified human CRP was dialyzed in PBS to remove so-
dium azide and its concentration was determined using the Micro
BCA protein assay (Pierce Chemical Co.). The purity of the hu-
man CRP was confirmed by SDS-PAGE. The requirement for
Ca
 
2
 
1
 
 in CRP-mediated serum killing was tested by preincubation
of cells in CRP (5 
 
m
 
g/ml) for 15 min at 37
 
8
 
C in either the buffer
described above or the same buffer in which 2 mM EDTA was
substituted for the 10 mM CaCl
 
2
 
. After washing the cells in
HBSS to remove unbound CRP, the cells were used in a bacteri-
cidal assay using CRP-depleted NHS as a source of complement
activity.
 
Binding of CRP to H. influenzae Variants.
 
ChoP
 
1
 
 and 
 
2
 
 vari-
ants were grown to OD
 
620
 
 
 
5
 
 0.4, washed in PBS, and resus-
pended in 0.02 M Tris (pH 7.2), 0.15 M NaCl, and either 10
mM CaCl
 
2
 
 or 2 mM EDTA. Purified human CRP (1.0 
 
m
 
g/10
 
8
 
cells) was allowed to bind to the cells in the presence of 2.5%
CRP-depleted NHS for additional buffering and to block non-
specific binding. After 15 min at 37
 
8
 
C with slow rotation, the
cells were washed in PBS and an aliquot was removed and treated
at 100
 
8
 
C in gel loading buffer for separation in 12% SDS-PAGE
and Western blot analysis. CRP was detected using an mAb to
human CRP followed by an alkaline phosphatase–conjugated
anti–mouse immunoglobulin.
 
Choline Incorporation. H. influenzae
 
 was radiolabeled by add-
ing [
 
3
 
H]choline (New England Nuclear Co., Boston, MA) to the
chemically defined medium (final concentration: 0.25 
 
m
 
Ci/ml).
 
H. influenzae
 
 was grown to an OD
 
620
 
 of 0.3 and washed three
times in an equal volume of PBS. Aliquots were removed for col- 
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ony immunoblotting and for determination of total cellular pro-
tein. The remainder of the sample was used to determine the in-
corporation of the label in whole cells.
 
Infant Rat Model of Nasopharyngeal Colonization.
 
Synchronized
pregnant Sprague-Dawley rats were purchased from Taconic
Farms (Germantown, N.Y.). 5-d-old infant rats were randomized
among litters. For intranasal inoculations, 10 
 
m
 
l of PBS-washed
midlog phase organisms adjusted to a density of 10
 
8
 
 CFU/ml
were inoculated into the left anterior naris. Animals receiving dif-
ferent phenotypic variants were housed in separate cages. Colony
counts were performed to ensure the inocula were of the desired
density. The nasopharynx was cultured by the slow instillation of
20–40 
 
m
 
l of sterile PBS into the left naris and withdrawal of the
initial 10 
 
ml discharge from the right naris. This ensured that the
fluid had passed through the nasopharynx. To assess the quantity
of organisms in nasal washes, serial dilutions in PBS were plated
on supplement brain heart infusion agar containing kanamycin
(20 mg/ml) to diminish the growth of non-Haemophilus contami-
nants.
Genotypic analysis of H. influenzae in human respiratory tract secre-
tions. Human respiratory tract secretions obtained from expec-
torated sputum or bronchoscopy were stored at 2808C and were
included only if shown subsequently to have a predominant
growth of H. influenzae on culture. Specimens containing puru-
lent sputum were from nonbacteremic adult patients hospitalized
with pneumonia. The diagnosis of H. influenzae pneumonia was
based on microscopic examination of gram-stained sputum that
revealed .20:1 ratio of inflammatory to epithelial cells and pro-
fuse gram-negative coccobacilli with only rare or no other organ-
isms (20). DNA was extracted from 50 ml of homogenized speci-
men by the addition of 1 ml of 1 M Tris-HCl (pH 7.6) and 1 ml
of proteinase K (5 mg/ml) followed by incubation at 358C for 60
min and then for 20 min at 1008C. This DNA was used as a tem-
plate to amplify the 59 region of lic1 using Taq polymerase and
primers 59-TCGAATCCGCAAAAGTCACCATTTATTGTG-
AAG-39 (forward) and 59-TGGAATTCGTCCGCCTAATAT-
GCCAGATAAC-39 (reverse) by PCR. Conditions for PCR in-
cluded thirty cycles in 1–2 mM Mg21, denaturing at 948C for 40 s,
annealing at 508C for 40 s and extension at 608C for 90 s. The
number of CAAT repeats was determined on the gel-extracted
PCR product by sequencing across this region using primer
59-TATTACATAATCTTTCAGCT-39.
Results
Structural Analysis of Variants in Expression of the ChoP
Epitope. Comparative analysis of LPS from TEPC-15–reac-
tive and –nonreactive colonies confirmed that the presence
of ChoP on the outer core region of the LPS accounted for
the difference. This was achieved by ESI-MS and 1H
NMR analysis of samples of O-deacylated LPS from a type
b strain. A notable feature of the 1H NMR that was partic-
ularly informative is the intense singlet at ca 3.25 ppm due
to the ChoP methyl protons (Fig. 1); a signal of significant
intensity is observed only in the O-deacylated LPS contain-
ing the ChoP epitope. It is now well established that H. in-
fluenzae express a heterogeneous mixture of LPS molecules.
A structural model has been advanced, comprised of a con-
served heptose-containing inner core trisaccharide moiety
attached via phosphorylated 3-deoxy-d-manno-octulosonic
acid to a lipid A component in which each of the heptose
residues can provide a point for elongation by hexose con-
taining oligosaccharide chains or for attachment of noncar-
bohydrate substituents (3, 8). ESI-MS of O-deacylated LPS
from TEPC-15–nonreactive colonies revealed a series of
related structures differing in the number of hexose residues
(Table 1) in which populations of LPS glycoforms contain-
ing three to nine hexose residues were identified. An addi-
tional parallel series of ions corresponding to subpopula-
tions of glycoforms containing ChoP substituents was
detected only for O-deacylated LPS from TEPC-15–reac-
tive colonies. In a lic2 mutant of this type b strain, detailed
structural studies have established the molecular environ-
ment in which the ChoP structure is expressed (5).
Contribution of ChoP to Susceptibility to Serum Bactericidal
Activity. Phase variants of a nontypable clinical isolate dif-
fering in the expression of ChoP were compared for their
ability to survive the bactericidal effect of human serum.
Survival of the ChoP1 variant in 10% NHS for 60 min was
,1% compared to the ChoP2 variant of the same strain
(Fig. 2 A). The difference in serum sensitivity did not ap-
pear to be caused by the presence of naturally acquired an-
tibody against ChoP since removal of IgG had no effect on
the increased susceptibility of the ChoP1 variant. How-
ever, killing of both H. influenzae variants appeared to be
dependent on the classical rather than alternative pathway
of complement activation as the addition of 0.05 M Mg21
EGTA to chelate divalent cations completely eliminated
serum killing of both variants (21).
The Effect of CRP on Serum Killing of H. influenzae.
The role of CRP (which binds both to ChoP in the pres-
ence of calcium and to the first component of comple-
ment) in the antibody-independent complement activation
by the classical pathway was examined (22, 23). Removal
of CRP from the serum eliminated the difference in serum
sensitivity between the ChoP variants of strain H233 (Fig.
2 A). The role of CRP in the bactericidal activity of serum
was confirmed by the addition of purified CRP to the
NHS depleted of CRP. The addition of CRP at a concen-
tration of 5 mg/ml completely restored the increased serum
Figure 1. 1H NMR spectra of O-deacylated LPS from TEPC-15–reac-
tive (a) and –nonreactive (b) colonies of H. influenzae strain RM7004.
The strong signal at ca 3.35 ppm in a is indicative of the presence of
ChoP. This signal is present only to the extent of ca 1% in b. Spectra were
recorded at 500 MHz in D2O containing 2 mM perdeutero EDTA and
10 mg/ml perdeutero SDS.634 The Role of Phosphorylcholine in H. influenzae Pathogenesis
killing of the ChoP1 variant but had no effect on the
ChoP2 variant. CRP (5 mg/ml) added to bacteria in the
absence of serum or in serum pretreated at 568C for 30 min
to remove complement activity had no effect on viability.
A dose response determination for the contribution of
CRP to serum bactericidal activity showed that the half-
maximal effect on killing of the ChoP1 variant was at a
CRP concentration of 10 ng/ml (Fig. 3). The effect of
CRP was shown to require the presence of calcium. There
was no increased killing of the ChoP1 variant when bacte-
ria were pretreated with CRP (5 mg/ml) in 2 mM EDTA
in comparison to pretreatment in 10 mM Ca21 (Fig. 2 B).
The direct interaction of purified CRP with strain H233
expressing ChoP and the requirement for calcium were
demonstrated by incubating both variants in CRP (5 mg/
ml) in the presence of Ca21 (10 mM) or EDTA (2 mM)
(Fig. 4). After washing the cells to remove the unbound
CRP, the binding of CRP to whole bacteria was detected
on Western blot analysis using an mAb to human CRP.
Binding of CRP required Ca21 and only the ChoP-con-
taining variant bound significant amounts of CRP. The
faint binding to the ChoP-variant in the presence of Ca21
probably represents the ,1% of ChoP1 revertants in this
population of organisms. The requirement of Ca21 raised
the possibility that bactericidal assays in the presence of
0.05 M Mg21 EGTA inhibited CRP binding rather than
the classical pathway of complement activation. However,
in bactericidal assays where bacteria were preincubated
with CRP in 10 mM Ca21, chelation of divalent cations
did not remove bound CRP but eliminated killing by
Table 1. Negative Ion ESI-MS Data and Proposed Compositions for O-deacylated LPS from TEPC-15–nonreactive and –reactive Colonies of 
Type b H. influenzae (RM 7004)
LPS
glycoform
Observed [M-3H]32 ions*
Molecular mass
Proposed composition
TEPC-15
non-reactive
TEPC-15
reactive Observed Calculated‡
Hex3 812.0 812.1 2439.0 2439.2 Hex3 3 Hep3 3 Pea1 3 KDO1 3 P1 3 LipidA-OH
866.7 2603.1 2604.3 ChoP 3 Hex3 3 Hep3 3 PEA1 3 KDO1 3 P1 3 
LipidA-OH
Hex4 865.9 865.7 2601.1 2601.3 Hex3 3 Hep3 3 Pea1 3 KDO1 3 P1 3 LipidA-OH 
Hex4 3 Hep3 3 PEA2 3
907.0 2724.0 2724.5 KDO1 3 P1 3 LipidA-OH
920.7 2765.1 2766.3 ChoP 3 Hex4 3 Hep3 3 PEA1 3 KDO1 3 P1 3 
LipidA-OH
962.0 2889.0 2889.4 ChoP 3 Hex4 3 Hep3 3 PEA1 3 KDO1 3 P1 3 
LipidA-OH
Hex5 919.9 919.8 2762.4 2763.5 Hex5 3 Hep3 3 PEA1 3 KDO1 3 P1 3 LipidA-OH 
Hex5 3 Hep3 3 PEA1 3
961.0 2886.0 2886.5 KDO1 3 P1 3 LipidA-OH
975.0 2928.0 2928.6 ChoP 3 Hex5 3 Hep3 3 PEA1 3 KDO1 3 P1 3 
LipidA-OH
1016.0 3051.0 3051.5 ChoP 3 Hex5 3 Hep3 3 PEA2 3 KDO1 3 P1 3 
LipidA-OH
Hex6 974.1 974.0 2025.0 2925.6 Hex6 3 Hep3 PEA1 3 KDO1 3 P1 3 LipidA-OH 
Hex6 3 Hep3 3 PEA2
1015.0 3048.0 3048.6 KDO1 3 P1 3 LipidA-OH
1029.0 3090.0 3090.7 ChoP 3 Hex6 3 Hep3 3 PEA1 3 KDO1 3 P1 3 LipidA-OH
Hex7 1027.8 2 3086.4 3087.8 Hex7 3 Hep3 3 PEA1 KDO1 3 P1 3 LipidA-OH
Hex8 1081.6 2 3247.8 3249.9 Hex8 3 Hep3 3 PEA1 3 KDO1 3 P1 3 LipidA-OH
Hex9 1136.1 2 3411.3 3412.0 Hex9 3 Hep3 3 PEA1 3 KDO1 3 P1 3 LipidA-OH
*The spectra were dominated by molecular peaks corresponding to triply deprotonated ions.
‡Average mass units used for calculation of molecular mass values based on proposed compositions as follows: Hex, 162.15; Hep, 192.17; KDO,
220.18; P, 79.98; PEA (phosphoethanolamine), 123.05; ChoP, 165.05.635 Weiser et al.
complement. This confirmed that CRP-mediated killing
requires complement activation by the classical pathway.
The Contribution of ChoP in Nasopharyngeal Colonization of
Infant Rats. The results of the bactericidal assays suggested
that the ChoP2 phenotype may be important in evading
humoral clearance mechanisms, but left unclear the contri-
bution of the ChoP1 phenotype to the biology of H. influ-
enzae. This question was addressed by comparing ChoP1
and ChoP2 variants in the infant rat model of nasopharyn-
geal colonization (Fig. 5). H. influenzae type b (strain
Eagan) was used in these experiments, since nontypable
isolates colonize poorly in animal models of carriage. After
an intranasal inoculum with 106 CFU of ChoP1 or 2 vari-
ants of a population .97% the desired phenotype, the
number of organisms obtained from nasal washes remained
relatively constant for up to 16 d. Animals receiving the
ChoP1 variant remained colonized with organisms of this
phenotype (.99%) when assessed by colony immunoblot-
ting. Those animals receiving the ChoP2 variant, in con-
trast, showed a gradual shift in the phenotype of organisms
cultured from the nasopharynx; at the final time point,
.73% of colonies had switched to the ChoP1 phenotype.
This finding suggests that decoration of the LPS with ChoP
was associated with an enhanced ability to persist within
the nasopharynx. This result was confirmed by showing the
diminished ability of a lic1 mutant of strain Eagan with a
constitutively ChoP2 phenotype to persist in the infant rat
nasopharynx. By day 10 after the inoculation the lic1 mu-
tant was present in significantly fewer numbers compared
to the ChoP1 variant. At day 16 after the inoculation, 8
out of 25 pups receiving the mutant had no detectable or-
ganisms in nasal washes versus 0 out of 22 receiving the
ChoP1 variant (P 5 0.0034, Fisher’s exact test).
Factors Affecting the Expression of ChoP. A number of
growth conditions were compared to determine whether
an environmental condition other than the availability of
choline might account for the increase in the proportion of
organism of the ChoP1 phenotype in the nasopharynx.
The frequency of phase variation between phenotypes and
the incorporation of choline were compared after growth
to midlog phase in a chemically defined medium under
various conditions including temperature (30–398C), pH
Figure 3. The dose response to CRP in serum bactericidal assays. Sur-
vival of phase variants expressing (solid circles) or not expressing (open
squares) ChoP in 10% NHS depleted of CRP with purified human CRP
added at the concentration indicated was compared. The percentage of
survival is the number of CFUs remaining compared to controls in which
complement was inactivated.
Figure 2. Serum bactericidal assay showing the contribution of immu-
noglobulin G and CRP to the survival of phase variants in the expression
of ChoP in NHS. ChoP1 (solid bar) or ChoP2 (hatched bar) variants of
nontypable strain H233 were grown to midlog phase and treated for 60
min in 10% pooled NHS. The percentage of survival is the number of
CFUs remaining compared to controls in which complement activity was
inactivated. In A, determinations were carried out in the presence of un-
treated NHS (lane 1), NHS depleted of IgG (lane 2), NHS depleted of
IgG with the addition of 0.05 M Mg21 EGTA (lane 3), NHS depleted of
IgG and CRP (lane 4), NHS depleted of CRP alone (lane 5), or NHS
depleted of CRP with the addition of purified human CRP (5 mg/ml)
(lane 6). In B, before use in the bactericidal assay with CRP-depleted
NHS, phase variants were pretreated with purified human CRP in the
presence of EDTA (lane 7) or Ca21 (lane 8). Values are the geometric
mean of at least three determinations in duplicate 6 SD.
Figure 4. The binding of hu-
man CRP to phase variants ex-
pressing ChoP in the presence of
calcium. Equivalent numbers of
phase variants with or without
ChoP were incubated in purified
CRP in the presence of Ca21 or
EDTA. After removing the un-
bound CRP, the bound CRP
was detected on Western blot
analysis using an mAb that rec-
ognizes human CRP.636 The Role of Phosphorylcholine in H. influenzae Pathogenesis
(6.8–8.0), supplemental NaCl (0–1 M), Ca21 (0.07–1.4
mM), Mg21 (0.49–4.9 mM), or glucose (0.17–20 mM). Al-
ternative sources of carbon (glycerol, pyruvate, lactate,
maltose, lactose, and galactose) at a concentration of 5 mM
in lieu of glucose were also examined. There was no signif-
icant difference for the ChoP1 variant in [3H]choline in-
corporation/milligrams of total cellular protein or in the
rate of reversion to the ChoP2 phenotype in colony im-
munoblots after growth under these conditions.
Chromosomal DNA extracted from organisms used to
inoculate rat pups was used in the PCR reaction to isolate
the 59-end of the lic1 locus to determine the number of re-
peats of 59-CAAT-39 within licA. As predicted the ChoP2
variants had a number of repeats (n 5 20) in which there
was no full-length translation product because no upstream
initiation codon was in frame with the licA gene (Fig. 6).
The ChoP1 variant, in contrast, had one fewer repeat (n 5
19) which would place two potential initiation codons (la-
beled a and b) that are in the same reading frame, in the
correct orientation for translation of the full-length licA
gene product. Colonies obtained from nasal washes at day
10 after the inoculation were immunoblotted and used as a
source of DNA for amplification of this same region. In
each instance those colonies retaining the phenotype of the
inoculum had the same number of repeats as those in the
inoculum. Organisms that switched from ChoP1 in the in-
Figure 5. The contribution
of ChoP expression to H. influ-
enzae carriage in an infant rat
model. ChoP variants of strain
Eagan and a lic1 mutant of this
strain were compared for their
ability to colonize the infant rat
nasopharynx. At each time point
the number and phenotype of
organism recovered in nasal
washes were determined. The
vertical axis represents the aver-
age number of organisms per an-
imal in the inoculum or nasal
washes on the day after intranasal
inoculation indicated (first bar at
each time point, ChoP1 inocu-
lum;  middle bar at each time
point, ChoP2 inoculum; last bar at each time point, lic1- mutant inoculum). Values are the geometric mean 6 SD for at least 22 pups per variant or mu-
tant in three separate experiments. The proportion of variants of the ChoP1 or ChoP2 phenotype in the inoculum or recovered in nasal washes at each
time point were determined by colony immunoblotting and is indicated (ChoP1 solid portion; ChoP2 hatched portion). Colony immunoblotting was not
performed for the constitutive lic1 mutant (open bars).
Figure 6. The correlation between ChoP
expression and the genotype of the lic1 lo-
cus. Shown above is the molecular mecha-
nism controlling phase variation in expres-
sion of ChoP. The nucleotide sequence at
the 59 end of lic1 contains a variable number
(n) of tandem repeats of CAAT. Variation
in the number of repeats creates a transla-
tional switch with possible translation prod-
ucts in phase with the open reading frame
of licA indicated below the nucleotide se-
quence. Three potential initiation codons
(boxed) labeled a, b and g are present in
only two of the three possible reading
frames since a and b are positioned in the
same phase. (In some strains the b codon is
GTG rather than ATG as shown.) Only
when an initiation codon is in frame with
the remainder of the open reading frame of
licA is there expression of ChoP. The table
on the bottom shows that ChoP expression
correlates with number of CAAT repeats
(n). Colonies obtained from nasal washes of
infant rats 10 d after the inoculation showed
a variant number of repeats only when the
phenotype in colony immunoblots was dif-
ferent from that of the corresponding inoc-
ulum.637 Weiser et al.
oculum to ChoP2 at day 10 acquired an additional repeat
as predicted (n 5 19 varied to n 5 20). Organisms that
switched from ChoP2 in the inoculum to ChoP1 at day 10
either gained one (n 5 21) or lost two repeats (n 5 18).
Thus in four out of four colonies with organisms reverting
to the ChoP1 phenotype, the number of repeats indicated
that licA was in frame with an initiation codon, although in
each case this was the g and not the a/b initiation codons.
It was concluded that the only identifiable factor contribut-
ing to variation in expression of ChoP on the LPS was the
number of repeats of 59-CAAT-39 in licA.
The Expression of ChoP in H. influenzae in the Human Res-
piratory Tract. In the animal model there was an absolute
correlation between the phenotype of organisms with re-
spect to ChoP and the number of repeats of CAAT in licA.
Based on this observation, the genotype of H. influenzae in
respiratory tract secretions from humans was determined in
order to deduce the in vivo phenotype (ChoP1 or 2) of or-
ganisms within the natural host. Purulent or nonpurulent
respiratory tract secretions were used as a source of DNA
for the PCR reaction to obtain the 59 end of lic1 for se-
quencing to determine the number of CAAT repeats. For
13 out of 14 specimens the number of repeats indicated
that the phenotype within the human respiratory tract was
ChoP1 (Table 2). As was demonstrated in the animal
model in instances of reversion to the ChoP1 phenotype,
there was a preference for a number of repeats that would
position the g initiation codon in frame with licA (12 out
of 14 for g, 1 out of 14 for a/b). The only specimens in
which the number of repeats would not predict licA trans-
lation from the g initiation codon were from purulent spu-
tum that fulfilled the case definition of nontypable H. influ-
enzae pneumonia (20).
Discussion
We previously reported that one of the phase-variable
structures on the H. influenzae LPS included the ChoP
epitope. Structural analysis in this study confirms that varia-
tion in the display of this epitope corresponds to the pres-
ence or absence of the ChoP structure on the oligosaccha-
ride of the LPS. Phase variants were then separated based
on the expression of ChoP as determined by reactivity with
mAbs recognizing this structure to address how ChoP con-
tributes to the pathogenesis of infection caused by H. influ-
enzae.
Since ChoP appears to be a common feature on the cell
surface of mucosal pathogens, particularly those residing in
the human respiratory tract, observations on H. influenzae
may be of relevance to the other species expressing the
ChoP structure/epitope (2, 12). This study was carried out
using H. influenzae because both the genetic and structural
basis of choline incorporation have now been defined in
this species (1, 5). We concentrated on nontypable isolates;
these organisms have been a predominant cause of disease
in adults for many years, and have become increasingly im-
portant in young children as H. influenzae type b disease has
begun to disappear due to widespread vaccination. Phase
variation in ChoP expression made it possible to examine
bacteria with and without this characteristic in an identical
genetic background. An additional feature favoring the use
of H. influenzae in these experiments was that, unlike the
pneumococcus, H. influenzae does not appear to have mul-
tiple surface proteins anchored to ChoP (25). The absence
of such proteins in H. influenzae allowed us to examine the
direct contribution of ChoP to pathogenesis.
H. influenzae is found exclusively in the human na-
sopharynx, where it is able to persist for extended periods.
In this study, an animal model of H. influenzae carriage was
used to demonstrate a gradual selection for ChoP1 phase
variants during prolonged colonization of the nasopharynx.
As predicted from this comparison of phase variants, a con-
stitutively ChoP2 mutant was cleared from the infant rat
nasopharynx significantly more rapidly than from the wild-
type controls. The capacity of ChoP1 variants to evade
clearance may help to explain why this structure may be
widely conserved among species that occupy a similar envi-
ronment but are otherwise highly distinct. However, this
study does not address the specific mechanism by which
decoration of the LPS with ChoP allows H. influenzae to
persist in the nasopharynx. ChoP, which is also found on
eukaryotic membrane lipids, may provide a selective ad-
vantage on the mucosal surface through molecular mimicry
of the host. In tissue explants from the human nasophar-
ynx, H. influenzae displays a tropism for the mucus layer
Table 2. Genotypic Analysis of the Number of CAAT Repeats (n) 
in licA in Nontypable H. influenzae (NTHI) in Human Respiratory 
Tract Secretions*
Genotype
(n 5)
NTHI
pneumonia‡
Predicted
phenotype
ChoP1/ChoP2
Corresponding
initiation codon(s)
6n o 1g
24 no 1g
24 no 1g
24 no 1g
18 no 1g
25 yes 1 a/b
30 yes 1g
33 no 1g
20 yes 2 none
18 yes 1g
21 yes 1g
18 no 1g
18 no 1g
18 no 1g
* The relationship between genotype, predicted phenotype, and the
designation of corresponding initiation codons is described in Fig. 6.
‡Clinical criteria for NTHI pneumonia are described in methods sec-
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(26). Phospholipids related to phosphatidylcholine, which
encompass the ChoP structure, are present in mucus. No
contribution of the lic1 genes to the interaction of H. influ-
enzae with human nasal turbinate tissue in culture was
demonstrated (26). However, these studies did not deter-
mine whether controls were phase on (ChoP1) or phase off
(ChoP2). In addition, it has been suggested that ChoP
contributes to adherence of the pneumococcus to host cells
by binding to the receptor for platelet activating factor,
whose natural ligand also contains ChoP (27). If ChoP is
functioning as an adhesin in H. influenzae, we would pre-
dict that its contribution to colonization would be apparent
at an earlier stage after the intranasal challenge than was ob-
served in the animal studies.
H. influenzae variants can be stratified into serum-resis-
tant and serum-sensitive phenotypes based on the presence
of ChoP. The increased serum sensitivity of the ChoP1
variants has been previously shown to correlate with the
presence of anti-ChoP antibody in human serum (1). This
study demonstrates that the difference in serum sensitivity
is independent of antibody yet involves the classical path-
way of complement activation. LPS structure is known to
affect the deposition of complement, but in previous re-
ports this involved alterations of the O-antigen and was
mediated by the alternative pathway (28). The activation of
the classical pathway in the absence of antibody was shown
to occur by the calcium dependent binding of CRP exclu-
sively to the ChoP1 variant. CRP is capable of substituting
for attached antibody in activating the complement cascade
by the classical pathway through binding to C1q (29, 30).
Therefore, it appears that CRP, an acute phase reactant,
contributes to innate immunity to bacterial pathogens
other than the pneumococcus in which its role in host pro-
tection has long been postulated (31). In the case of the
pneumococcus, CRP is thought to promote clearance by
opsonization, whereas for H. influenzae CRP contributes to
killing through the bactericidal activity of complement.
The effect of CRP on serum bactericidal activity against H.
influenzae strain H233 occurred at concentrations as low as
10 ng/ml. This is well below the level of CRP in normal,
unstimulated human serum (,200 ng/ml). A further impli-
cation of these results is that the innate immunity mediated
by CRP may be particularly important in protection
against certain invasive mucosal pathogens, such as the
pneumococcus, meningococcus, and some H. influenzae
strains, in the time preceding emergence of antibody-medi-
ated opsonizing and/or bactericidal activity.
We have noted that for H. influenzae, as well as for the
pathogenic Neisseria and the pneumococcus, there is varia-
tion between phenotypes with greater or lesser amounts of
the ChoP structure/epitope (references 1 and 14 and Weiser,
J.N., J. Goldberg, N. Pan, and M. Virgi, manuscript sub-
mitted for publication). This suggests that there may be a
role for both these phenotypes in the interaction of ChoP-
expressing pathogens and their host. H. influenzae has the
ability to switch off expression of ChoP, which eliminates
binding of CRP and the subsequent activation of comple-
ment through the classical pathway. This suggests that the
biological role of the ChoP2 phenotype might be evasion
of CRP-mediated clearance. It is predicted that there
would be a selection for the ChoP2 variants from among
the predominantly ChoP1 population in the commensal
state whenever the concentration of CRP and complement
is sufficient. This may occur during invasive infection, lo-
calized inflammation, or systemic inflammatory states when
serum levels of CRP rise precipitously. It was not possible
to demonstrate a selection for ChoP2 variants among the
infant rats developing bacteremia after the intranasal inocu-
lation. Unlike humans, CRP expression in rats is at consti-
tutively low levels for the first 15 d after gestation (32). The
30-fold increase in CRP levels in normal adult rats may
also account for the age-related sensitivity of this model
host to invasive infection by H. influenzae.
The mechanism-controlling phase variation in ChoP ex-
pression provided a means of determining the phenotype of
organisms without the need for in vitro culture (11).
Avoiding in vitro growth was desirable because of the high
rate of phenotypic switching. In preliminary experiments,
we demonstrated that the only factor which affected phase
variation was the number of repeats of CAAT within the
lic1. In each of eight phenotypic revertants obtained from
nasal washes of infant rats, there was a corresponding shift
in the number of repeat units. The phenotype of organisms
in the respiratory tract of the natural host was then deduced
by determining the genotype with respect to lic1. If ChoP
contributes to persistence in the nasopharynx, organisms in
respiratory tract secretions at any point in time would tend
to have ChoP that contains LPS. As expected, the over-
whelming majority (92.9%) of patients with H. influenzae
identified in their respiratory secretions had a number of
repeats which would predict translation of the full length
licA gene and expression of the ChoP1 phenotype. This
finding supports the hypothesis that the ChoP decoration
of the LPS contributes to the ability of H. influenzae to col-
onize and persist within the human respiratory tract, the
initial step in the pathogenesis of infection.
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